Age-Related Macular Degeneration and Mortality: A Systematic Review and Meta-Analysis

References

• Gohdes DM, Balamurugan A, Larsen BA, et al. Age-related eye diseases: an emerging challenge for public health professionals. Prevent Chronic Dis 2005;2:1–6.
   Google Scholar
• Congdon N, O’Colmain B, Klaver CCW, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004;122:477–485.
   PubMed Web of Science ®Google Scholar
• Chaum E, Winborn CS, Bhattacharya S. Genomic regulation of senescence and innate immunity signaling in the retinal pigment epithelium. Mamm Genome 2015;26:210–221.
   PubMed Web of Science ®Google Scholar
• Chen W, Stambolian D, Edwards AO, et al. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A 2010;107:7401–7406.
   PubMed Web of Science ®Google Scholar
• Yu Y, Bhangale TR, Fagerness J, et al. Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Human Mol Genet 2011;20:3699–3709.
   PubMed Web of Science ®Google Scholar
• Donoso LA, Kim D, Frost A, et al. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2006;51:137–152.
   PubMed Web of Science ®Google Scholar
• Keilhauer CN, Fritsche LG, Guthoff R, et al. Age-related macular degeneration and coronary heart disease: evaluation of genetic and environmental associations. Eur J Med Genet 2013;56:72–79.
   PubMed Web of Science ®Google Scholar
• Whitcup SM, Sodhi A, Atkinson JP, et al. The role of the immune response in age-related macular degeneration. Intl J Inflam 2013;2013:1–10.
   Google Scholar
• Telander DG. Inflammation and age-related macular degeneration (AMD). Sem Ophthalmol 2011;26:192–197.
   PubMed Web of Science ®Google Scholar
• Myers CE, Klein BEK, Gangnon R, et al. Cigarette smoking and the natural history of age-related macular degeneration. The Beaver Dam Eye Study. Ophthalmology 2014;121:1949–1955.
   PubMed Web of Science ®Google Scholar
• Chong EW, Simpson JA, Robman LD, et al. Red meat and chicken consumption and its association with age-related macular degeneration. Am J Epidemiol 2009;169:867–876.
   PubMed Web of Science ®Google Scholar
• Amirul Islam FM, Chong EW, Hodge AM, et al. Dietary patterns and their associations with age-related macular degeneration: the Melbourne collaborative cohort study. Ophthalmology 2014;121:1428–1434.
   PubMed Web of Science ®Google Scholar
• Hyman L, Schachat AP, He Q, et al., for the Age-Related Macular Degeneration Risk Factors Study Group. Hypertension, cardiovascular disease, and age-related macular degeneration. Arch Ophthalmol 2000;118:351–358.
   Google Scholar
• Smith W, Mitchell P, Leeder SR, et al. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 1998;116:583–587.
   PubMed Web of Science ®Google Scholar
• Howard KP, Klein BEK, Lee KE, et al. Measures of body shape and adiposity as related to incidence of age-related eye diseases: observations from the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 2014;55:2592–2598.
   PubMed Web of Science ®Google Scholar
• Vingerling JR, Dielemans I, Bots ML, et al. Age-related macular degeneration is associated with atherosclerosis – the Rotterdam Study. Am J Epidemiol 1995;142:404–409.
   PubMed Web of Science ®Google Scholar
• Duan Y, Mo J, Klein R, et al. Age-related macular degeneration is associated with incident myocardial infarction among elderly Americans. Ophthalmology 2007;114:732–737.
   PubMed Web of Science ®Google Scholar
• Ikram MK, Mitchell P, Klein R, et al. Age-related macular degeneration and long-term risk of stroke subtypes. Stroke 2012;43:1681–1683.
   PubMed Web of Science ®Google Scholar
• Chong EW, Wang YY, Robman LD, et al. Age related macular degeneration and total hip replacement due to osteoarthritis or fracture: Melbourne Collaborative Cohort Study. Plos One 2015;10:11.
   Web of Science ®Google Scholar
• McCarty CA, Nanjan MB, Taylor HR. Vision impairment predicts 5 year mortality. Br J Ophthalmol 2001;85:322–326.
   PubMed Web of Science ®Google Scholar
• Casten RJ, Rovner BW. Update on depression and age-related macular degeneration. Curr Opin Ophthalmol 2013;24:239–243.
   PubMed Web of Science ®Google Scholar
• Cuijpers P, Smit H. Excess mortality in depression: a meta-analysis of community studies. J Affect Disord 2002;72:227–236.
   PubMed Web of Science ®Google Scholar
• Johnell O, Kanis JA. An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporosis Int 2004;15:897–902.
   PubMed Web of Science ®Google Scholar
• Buch H, Vinding T, la Cour M, et al. Age-related maculopathy: a risk indicator for poorer survival in women – The Copenhagen city eye study. Ophthalmology 2005;112:305–12.
   PubMed Web of Science ®Google Scholar
• Cugati S, Cumming RG, Smith W, et al. Visual impairment, age-related macular degeneration, cataract, and long-term mortality: the Blue Mountains Eye Study. Arch Ophthalmol 2007;125:917–924.
   PubMedGoogle Scholar
• Pedula KL, Coleman AL, Yu F, et al. Age-related macular degeneration and mortality in older women: The Study of Osteoporotic Fractures. J Am Geriatr Soc 2015;63:910–917.
   PubMed Web of Science ®Google Scholar
• Fisher DE, Jonasson F, Eiriksdottir G, et al. Age-related macular degeneration and mortality in community-dwelling elders: the Age, Gene/Environment Susceptibility Reykjavik Study. Ophthalmology 2015;122:382–390.
   PubMed Web of Science ®Google Scholar
• Chew EY, Clemons TE, Agron E, et al. Long-term effects of vitamins C and E, beta-Carotene, and zinc on age-related macular degeneration AREDS report no. 35. Ophthalmology 2013;120:1604–1611.
   Google Scholar
• Wong TY, Tikellis G, Sun C, et al. Age-related macular degeneration and risk of coronary heart disease – The Atherosclerosis Risk in Communities Study. Ophthalmology 2007;114:86–91.
   PubMed Web of Science ®Google Scholar
• Borger PH, Van Leeuwen R, Hulsman CAA, et al. Is there a direct association between age-related eye diseases and mortality? The Rotterdam study. Ophthalmology 2003;110:1292–1296.
   PubMed Web of Science ®Google Scholar
• Ferris FL, 3rd, Wilkinson CP, Bird A, et al. Clinical classification of age-related macular degeneration. Ophthalmology 2013;120:844–851.
   PubMed Web of Science ®Google Scholar
• Hamling J, Lee P, Weitkunat R, et al. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med 2008;27:954–970.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
   PubMed Web of Science ®Google Scholar
• Clemons TE, Kurinij N, Sperduto RD. Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. Arch Ophthalmol 2004;122:716–726.
   Google Scholar
• Klein R, Klein BE, Moss SE. Age-related eye disease and survival: the Beaver Dam Eye Study. Arch Ophthalmol 1995;113:333–339.
   PubMed Web of Science ®Google Scholar
• Xu L, Li YB, Wang YX, et al. Age-related macular degeneration and mortality: the Beijing Eye Study. Ophthalmologica 2008;222:378–379.
   PubMed Web of Science ®Google Scholar
• Xu L, Wang YX, Wang J, et al. Mortality and ocular diseases: the Beijing Eye Study. Ophthalmology 2009;116:732–738.
   PubMed Web of Science ®Google Scholar
• Chew EY, Clemons T. Vitamin E and the age-related eye disease study supplementation for age-related macular degeneration. Arch Ophthalmol 2005;123:395–396.
   PubMedGoogle Scholar
• Lee DJ, Gomez-Marin O, Lam BL, et al. Visual acuity impairment and mortality in US adults. Arch Ophthalmol 2002;120:1544–1550.
   PubMed Web of Science ®Google Scholar
• Thompson JR, Gibson JM, Jagger C. The association between visual impairment and mortality in elderly people. Age Ageing 1989;18:83–88.
   PubMed Web of Science ®Google Scholar
• Golan S, Shalev V, Goldstein M, et al. The rate of myocardial infarction events among patients with age-related macular degeneration: a population-based study. Graefe’s Arch Clin Exp Ophthalmol 2011;249:179–182.
   PubMed Web of Science ®Google Scholar
• Day S, Acquah K, Platt A, et al. Association of vitamin D deficiency and age-related macular degeneration in Medicare beneficiaries. Arch Ophthalmol 2012;130:1070–1071.
   PubMedGoogle Scholar
• Al-Qureshi S, Shaikh S. Intravitreous bevacizumab adult safety data: the evidence so far. Clin Exp Ophthalmol 2012;40:3–5.
   PubMed Web of Science ®Google Scholar
• Amano S. Systemic vascular safety of ranibizumab for age-related macular degeneration: systematic review and meta-analysis of randomized trials. Ophthalmol 2014;121:2193–2203.
   PubMed Web of Science ®Google Scholar
• Bengtsson B. Survival of elderly ophthalmic out-patients. Acta Ophthalmol 1984;62:725–730.
   Web of Science ®Google Scholar
• Curtis LH, Hammill BG, Schulman KA, et al. Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration. Arch Ophthalmol 2010;128:1273–1279.
   PubMed Web of Science ®Google Scholar
• Krumpaszky HG, Dietz K, Mickler A, et al. Mortality in blind subjects – A population-based study on social security files from Baden-Wurttemberg. Ophthalmologica 1999;213:48–53.
   PubMed Web of Science ®Google Scholar
• Rogot E, Goldberg ID, Goldstein H. Survivorship and causes of death among blind. J Chronic Dis 1966;19:179.
   PubMedGoogle Scholar
• Roth DB, King A, Weiss M, et al. Systemic adverse events after bevacizumab. Ophthalmology 2009;116:1226.
   PubMed Web of Science ®Google Scholar
• Wong D, Joussen AM. The safety of using anti-VEGF: is there strength in numbers? Graefes Arch Clin Exp Ophthalmol 2011;249:161–162.
   PubMed Web of Science ®Google Scholar
• Wang YX, Zhang JS, You QS, et al. Ocular diseases and 10-year mortality: the Beijing Eye Study 2001/2011. Acta Ophthalmol 2014;92:E424–E8.
   Google Scholar
• Cheung N, Shankar A, Klein R, et al. Age-related macular degeneration and cancer mortality in the Atherosclerosis Risk in Communities Study. Arch Ophthalmol 2007;125:1241–1247.
   PubMedGoogle Scholar
• Knudtson MD, Klein BEK, Klein R. Age-related eye disease, visual impairment, and survival – The Beaver Dam Eye Study. Arch Ophthalmol 2006;124:243–249.
   PubMedGoogle Scholar
• Thiagarajan M, Evans JR, Smeeth L, et al. Cause-specific visual impairment and mortality: results from a population-based study of older people in the United Kingdom. Arch Ophthalmol 2005;123:1397–1403.
   PubMedGoogle Scholar
• Tan JSL, Wang JJ, Liew G, et al. Age-related macular degeneration and mortality from cardiovascular disease or stroke. Br J Ophthalmol 2008;92:509–512.
   PubMed Web of Science ®Google Scholar
• Schlomer GL, Bauman S, Card NA. Best practices for missing data management in counseling psychology. J Counsel Psychol 2010;57:1–10.
   PubMed Web of Science ®Google Scholar
• Hernán MA, Hernández-Díaz S, Werler MM, et al. Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol 2002;155:176–184.
   PubMed Web of Science ®Google Scholar
• Ambati J, Ambati BK, Yoo SH, et al. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003;48:257–293.
   PubMed Web of Science ®Google Scholar
• Li CM, Chung BH, Presley JB, et al. Lipoprotein-like particles and cholesteryl esters in human Bruch’s membrane: initial characterization. Invest Ophthalmol Vis Sci 2005;46:2576–2586.
   PubMed Web of Science ®Google Scholar
• Ebrahimi KB, Handa JT. Lipids, lipoproteins, and age-related macular degeneration. J Lipids 2011;2011:e1–e14.
   Google Scholar
• Hansson GK. Mechanisms of disease – Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685–1695.
   PubMed Web of Science ®Google Scholar
• Malek G, Lad EM. Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration. Cell Mol Life Sci 2014;71:4617–4636.
   PubMed Web of Science ®Google Scholar
• Hong T, Tan AG, Mitchell P, et al. A review and meta-analysis of the association between C-reactive protein and age-related macular degeneration. Surv Ophthalmol 2011;56:184–194.
   PubMed Web of Science ®Google Scholar
• Lange LA, Carlson CS, Hindorff LA, et al. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 2006;296:2703–2711.
   PubMed Web of Science ®Google Scholar